Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association
Europace · 05.03.2025 · 27 (3)
DOI: 10.1093/europace/euaf019 ↗Kurz gefasst
Leitlinie in der Zeitschrift Europace, online erschienen am 12.03.2025. Verfasst von Wolfram Doehner und 20 weiteren Autor:innen. Beteiligte Einrichtung: Berlin Institute of Health Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Föhrerstr. 15, Berlin 13353, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiology, Stroke. Die Arbeit wurde bisher 159-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bayer, Sanofi, Medtronic.
Themen: Schlaganfall
Abstract (Originalsprache)
Atrial fibrillation (AF) is one of the most common cardiac diseases and a complicating comorbidity for multiple associated diseases. Many clinical decisions regarding AF are currently based on the binary recognition of AF being present or absent with the categorical appraisal of AF as continued or intermittent. Assessment of AF in clinical trials is largely limited to the time to (first) detection of an AF episode. Substantial evidence shows, however, that the quantitative characteristic of intermittent AF has a relevant impact on symptoms, onset, and progression of AF and AF-related outcomes, including mortality. Atrial fibrillation burden is increasingly recognized as a suitable quantitative measure of intermittent AF that provides an estimate of risk attributable to AF, the efficacy of antiarrhythmic treatment, and the need for oral anticoagulation. However, the diversity of assessment methods and the lack of a consistent definition of AF burden prevent a wider clinical applicability and validation of actionable thresholds of AF burden. To facilitate progress in this field, the AF burden Consensus Group, an international and multidisciplinary collaboration, proposes a unified definition of AF burden. Based on current evidence and using a modified Delphi technique, consensus statements were attained on the four main areas describing AF burden: Defining the characteristics of AF burden, the recording principles, the clinical relevance in major clinical conditions, and implementation as an outcome in the clinic and in clinical trials. According to this consensus, AF burden is defined as the proportion of time spent in AF expressed as a percentage of the recording time, undertaken during a specified monitoring duration. A pivotal requirement for validity and comparability of AF burden assessment is a continuous or near-continuous duration of monitoring that needs to be reported together with the AF burden assessment. This proposed unified definition of AF burden applies independent of comorbidities and outcomes. However, the disease-specific actionable thresholds of AF burden need to be defined according to the targeted clinical outcomes in specific populations. The duration of the longest episode of uninterrupted AF expressed as a time duration should also be reported when appropriate. A unified definition of AF burden will allow for comparability of clinical study data to expand evidence and to establish actionable thresholds of AF burden in various clinical conditions. This proposed definition of AF burden will support risk evaluation and clinical treatment decisions in AF-related disease. It will further promote the development of clinical trials studying the clinical relevance of intermittent AF. A unified approach on AF burden will finally inform the technology development of heart rhythm monitoring towards validated technology to meet clinical needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Berlin Institute of Health Center for Regenerative Therapies, Charité -Universitätsmedizin Berlin, Föhrerstr. 15, Berlin 13353, Germany.
- Deutsches Herzzentrum der Charité, Department of Cardiology Angiology and Intensive Care Medicine (Campus Virchow), Charité - Universitätsmedizin Berlin, German Centre for Cardiovascular Research (DZHK) partner site Ber…
- Center for Stroke Research Berlin, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
- Division of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
- Medical Faculty, University of Belgrade, Dr Subotica 13, 11000 Belgrade, Serbia.
- Cardiology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.
ORCID-Profile: Wolfram Doehner, Giuseppe Boriani, Tatjana Potpara, Carina Blomstrom-Lundqvist, Rod Passman, Luciano A Sposato, Dobromir Dobrev, Ben Freedman, Isabelle C Van Gelder, Taya V Glotzer, Jeff S Healey, Theodore Karapanayiotides, Gregory Y H Lip, Jose Luis Merino, George Ntaios, Renate B Schnabel, Jesper H Svendsen, Emma Svennberg, Rolf Wachter, Karl Georg Haeusler, A John Camm
Förderung
- Bayer
- Sanofi
- Medtronic
- Daiichi Sankyo
- Boston Scientific
Zitieren
APA
Doehner, W., Boriani, G., Potpara, T., Blomstrom-Lundqvist, C., Passman, R., Sposato, L. A., Dobrev, D., Freedman, B., Van Gelder, I. C., Glotzer, T. V., Healey, J. S., Karapanayiotides, T., Lip, G. Y. H., Merino, J. L., Ntaios, G., Schnabel, R. B., Svendsen, J. H., Svennberg, E., Wachter, R., …, & Camm, A. J. (2025). Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association. Europace, 27(3). https://doi.org/10.1093/europace/euaf019
Vancouver
Doehner W, Boriani G, Potpara T, Blomstrom-Lundqvist C, Passman R, Sposato LA, et al. Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association. Europace. 2025;27(3). doi:10.1093/europace/euaf019
BibTeX
@article{Doehner2025,
author = {Doehner, Wolfram and Boriani, Giuseppe and Potpara, Tatjana and Blomstrom-Lundqvist, Carina and Passman, Rod and Sposato, Luciano A and Dobrev, Dobromir and Freedman, Ben and Van Gelder, Isabelle C and Glotzer, Taya V and Healey, Jeff S and Karapanayiotides, Theodore and Lip, Gregory Y H and Merino, Jose Luis and Ntaios, George and Schnabel, Renate B and Svendsen, Jesper H and Svennberg, Emma and Wachter, Rolf and Haeusler, Karl Georg and Camm, A John},
title = {Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association},
journal = {Europace},
year = {2025},
volume = {27},
number = {3},
doi = {10.1093/europace/euaf019}
}
EUVIMED